BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 30171069)

  • 1. The SCF
    Choppara S; Ganga S; Manne R; Dutta P; Singh S; Santra MK
    J Biol Chem; 2018 Oct; 293(42):16291-16306. PubMed ID: 30171069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of FBXO31 by APC/C is regulated by AKT- and ATM-mediated phosphorylation.
    Choppara S; Malonia SK; Sankaran G; Green MR; Santra MK
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):998-1003. PubMed ID: 29343641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage.
    Santra MK; Wajapeyee N; Green MR
    Nature; 2009 Jun; 459(7247):722-5. PubMed ID: 19412162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-box protein FBXO31 directs degradation of MDM2 to facilitate p53-mediated growth arrest following genotoxic stress.
    Malonia SK; Dutta P; Santra MK; Green MR
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8632-7. PubMed ID: 26124108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The centrosomal E3 ubiquitin ligase FBXO31-SCF regulates neuronal morphogenesis and migration.
    Vadhvani M; Schwedhelm-Domeyer N; Mukherjee C; Stegmüller J
    PLoS One; 2013; 8(2):e57530. PubMed ID: 23469015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXO31 Suppresses Gastric Cancer EMT by Targeting Snail1 for Proteasomal Degradation.
    Zou S; Ma C; Yang F; Xu X; Jia J; Liu Z
    Mol Cancer Res; 2018 Feb; 16(2):286-295. PubMed ID: 29117943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of the phosphorylation-independent recognition of cyclin D1 by the SCF
    Li Y; Jin K; Bunker E; Zhang X; Luo X; Liu X; Hao B
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):319-324. PubMed ID: 29279382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor FBXO31 preserves genomic integrity by regulating DNA replication and segregation through precise control of cyclin A levels.
    Dutta P; Islam S; Choppara S; Sengupta P; Kumar A; Kumar A; Wani MR; Chatterjee S; Santra MK
    J Biol Chem; 2019 Oct; 294(41):14879-14895. PubMed ID: 31413110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
    Spagnol V; Oliveira CAB; Randle SJ; Passos PMS; Correia CRSTB; Simaroli NB; Oliveira JS; Mevissen TET; Medeiros AC; Gomes MD; Komander D; Laman H; Teixeira FR
    Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129754. PubMed ID: 33010352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCF-FBXO31 E3 ligase targets DNA replication factor Cdt1 for proteolysis in the G2 phase of cell cycle to prevent re-replication.
    Johansson P; Jeffery J; Al-Ejeh F; Schulz RB; Callen DF; Kumar R; Khanna KK
    J Biol Chem; 2014 Jun; 289(26):18514-25. PubMed ID: 24828503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
    Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
    J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBXO31 protects against genomic instability by capping FOXM1 levels at the G2/M transition.
    Jeffery JM; Kalimutho M; Johansson P; Cardenas DG; Kumar R; Khanna KK
    Oncogene; 2017 Feb; 36(7):1012-1022. PubMed ID: 27568981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex.
    Kumar R; Neilsen PM; Crawford J; McKirdy R; Lee J; Powell JA; Saif Z; Martin JM; Lombaerts M; Cornelisse CJ; Cleton-Jansen AM; Callen DF
    Cancer Res; 2005 Dec; 65(24):11304-13. PubMed ID: 16357137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoform-specific SCF(Fbw7) ubiquitination mediates differential regulation of PGC-1α.
    Trausch-Azar JS; Abed M; Orian A; Schwartz AL
    J Cell Physiol; 2015 Apr; 230(4):842-52. PubMed ID: 25204433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCF
    Cai L; Liu L; Li L; Jia L
    Cell Signal; 2020 Jan; 65():109440. PubMed ID: 31678254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Biology of F-box Proteins: The SCF Family of E3 Ubiquitin Ligases.
    Nguyen KM; Busino L
    Adv Exp Med Biol; 2020; 1217():111-122. PubMed ID: 31898225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest.
    Chen BB; Glasser JR; Coon TA; Mallampalli RK
    Oncogene; 2012 May; 31(20):2566-79. PubMed ID: 22020328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.
    Lin DI; Barbash O; Kumar KG; Weber JD; Harper JW; Klein-Szanto AJ; Rustgi A; Fuchs SY; Diehl JA
    Mol Cell; 2006 Nov; 24(3):355-66. PubMed ID: 17081987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feedback-regulated transcriptional repression of FBXO31 by c-Myc triggers ovarian cancer tumorigenesis.
    Islam S; Dutta P; Sahay O; Gopalakrishnan K; Muhury SR; Parameshwar P; Shetty P; Santra MK
    Int J Cancer; 2022 May; 150(9):1512-1524. PubMed ID: 34706096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mechanism of RhoA ubiquitination and degradation: roles of SCF(FBXL19) E3 ligase and Erk2.
    Wei J; Mialki RK; Dong S; Khoo A; Mallampalli RK; Zhao Y; Zhao J
    Biochim Biophys Acta; 2013 Dec; 1833(12):2757-2764. PubMed ID: 23871831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.